文献速递临床试验与 GCP基础与转化研究

整合医学康复治疗脑瘫儿童:多中心实用随机对照试验研究方案

Integrative medicine rehabilitation for children with cerebral palsy: a study protocol for a multicenter pragmatic randomized controlled trial.
PubMed 文献 · Trials · 2020-08-17

主要结局为粗大运动功能量表-88(GMFM-88)评分,次要结局包括目标达成量表、韩国贝利婴幼儿发育量表III、儿科生活质量量表及不良事件。旨在评估IMR的有效性与安全性。

要点

  • IMR包括每周3次针灸(头针和体针)及每日2次中药提取物(Yukgunza-tang和Yukmijihwang-tang),联合常规康复。
  • 主要结局为GMFM-88评分,评估时间点为基线、12周和24周。
  • 这是韩国首个评估IMR治疗脑瘫儿童的实用随机对照试验。

核心结论

  • 本研究将评估整合医学康复(IMR)联合常规康复对脑瘫儿童的有效性和安全性,结果有助于判断IMR是否为此类患儿的有效治疗途径。

研究设计与样本

  • 研究周期为12周干预,随访至24周,评估在基线、12周和24周进行。

关键数值与推荐

  • 主要结局为粗大运动功能量表-88(GMFM-88)评分。
  • 次要结局包括目标达成量表(GAS)、韩国贝利婴幼儿发育量表III(K-BSID-III)、儿科生活质量量表(PedsQL)评分及不良事件。
  • IMR方案:针灸(头针和肢体针)每周3次,中药提取物(Yukgunza-tang和Yukmijihwang-tang)每日2次,与常规康复并行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditional Korean medicine (TKM) has been employed for the treatment of children with cerebral palsy in Korea; however, the addition of TKM to usual rehabilitation (UR) treatment is hindered by insufficient evidence of clinical improvement with TKM in patients with cerebral palsy. In this study, we will evaluate the effectiveness and safety of integrative medicine rehabilitation (IMR) for cerebral palsy through a randomized controlled clinical study. METHODS: Eighty children (2-6 years old) diagnosed with cerebral palsy will be recruited and randomly divided into groups A and B. Patients in group A will receive IMR with UR, while those in group B will receive only UR during weeks 1-12 of the study. IMR includes acupuncture treatment (head and limb acupuncture) three times a week and the administration of herbal medicine (Yukgunza-tang and Yukmijihwang-tang extracts) twice a day in parallel with UR. Evaluations will be conducted at the beginning of the study and at 12 and 24 weeks (follow-up). The primary outcome is the Gross Motor Function Measure-88 score, and the secondary outcomes are the scores for the Goal Attainment Scale, Korean Bayley Scales of Infant Development III, and the Pediatric Quality of Life Inventory, and adverse events. DISCUSSION: This will be the first pragmatic randomized controlled trial to evaluate the efficacy and safety of IMR in children with cerebral palsy in Korea. The results will help to demonstrate if IMR is an effective therapeutic approach for cerebral palsy. TRIAL REGISTRATION: Ministry of Food and Drug Safety 31361 ( http://www.mfds.go.kr ). Registered on 29 June 2017. Clinical Research Information Service KCT0002620 ( https://cris.nih.go.kr/cris/search/search_result_st01.jsp?seq=9819 ). Registered on 29 December 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lee MJ, Yun YJ, Yu SA, et al. Integrative medicine rehabilitation for children with cerebral palsy: a study protocol for a multicenter pragmatic randomized controlled trial. Trials. 2020. PMID: 32807229. doi:10.1186/s13063-020-04639-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。